MJ Gleeson warned that Adjusted Group PBT for the year will be approximately £7.5m lower than current market expectations of £17.8m. Delays in completing land sales, including one site representing approximately 50% of forecast plots, deferred several transactions into the next financial year.
Oxford Instruments reported adjusted operating profit of £73.7m, ahead of £71.3m consensus. Despite a 3.0% organic revenue decline, record order intake grew 8.0% organically to £450.4m. The full-year dividend was raised to 23.6p alongside a £62.2m share buyback.
Thor Energy reported preliminary Phase-2 survey results at its HY-Range project, recording natural hydrogen concentrations up to 3% (30,000 ppm). The results far exceeded management expectations and validated three high-priority focus areas. Thor is fully self-funded for an upcoming 2D seismic programme.
Fever-Tree Drinks said it remains confident of achieving full-year market expectations for adjusted revenue and EBITDA. The company announced a further £30m extension to its on-going share buyback programme, with £18.9m returned from the ongoing £30m tranche as of 5 June 2026. Progress in the US partnership and strong momentum in Australia supported confidence, alongside extended energy hedging through 2028.
Bellway reiterated full-year volume guidance of 9,300-9,500 homes and underlying profit of £320m-£330m. Customer demand moderated in April and May following mortgage rate rises. Private reservation rates fell 6.2% to 151 per week and the order book value declined to £1,570m.
Keller Group was awarded a $207m contract variation for the I-40 highway reconstruction in the US, bringing its total project value to c$380m. The award lifted the group order book to a record £1.9bn and management reiterated its 2026 full-year guidance.
RELX PLC initiated a £200 million share buyback tranche to run from 9 June to 26 June 2026. This follows a completed £150 million programme and forms part of a planned £2.25 billion capital return for 2026.
First Class Metals PLC raised gross proceeds of £1,000,000 through a placing at 3.8p per share, a 9.5% discount to the previous close. The capital will support exploration at the Sunbeam Project, including a drill programme at the Pettigrew Prospect scheduled for H2 2026.
Eich Geothermal Resource Potential Increase by 50%
Cindrigo Holdings reported a 50% increase in the energy potential at its Eich licence to 157.8 MW. Subsurface analysis also supports potential for 7,230 tonnes per annum of lithium carbonate equivalent. First drilling is planned for 2027 at shallower-than-anticipated depths.
Alien Metals noted drilling results from joint venture partner West Coast Silver showing silver mineralisation extends 70m north of the Elizabeth Hill maiden resource. Best intersections included 60m at 25 g/t Ag from surface. The system remains open at depth and along strike.
Rockfire Resources reported high-grade results from its Molaoi deposit in Greece. Laboratory assays for hole HMO-016 included 0.76m at 22.4% zinc and 187g/t silver. Management stated results continue to build the case for a resource upgrade to the indicated category.
Time Finance said its gross lending book reached a record £250m, up from £217m a year earlier. This marks the 20th consecutive quarter of growth as the company targets £300m by May 2028.
Zephyr Energy plc confirmed the Paradox project pipeline is structurally sound after a technical evaluation. The results allow regulatory approval for gas export to commence. Planning for additional wells and asset-level funding discussions are progressing alongside gas processing design.
PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
PureTech Health's founded entity, Seaport Therapeutics, reported positive Phase 1 multiple-ascending dose data for GlyphAgo. Successful safety and pharmacokinetic results support the initiation of two parallel Phase 2 trials for generalized anxiety disorder, with the first study expected to begin in the second half of 2026.
Rome Resources expects to commence its 2026 field programme in New Brunswick, Canada this week. The exploration programme, costing up to CA$150k, targets tin, tungsten, and indium across three priority areas and includes over 500 surface and trench samples.
VAALCO Energy resumed production at the Baobab field offshore Côte d'Ivoire following a successful nine-month FPSO refurbishment. Production has resumed from four producing wells, the field is performing in line with Vaalco's expectations, and Phase 5 drilling is planned for the second half of 2026. The CI-40 block license has been extended through 2038.
Orosur Mining discovered new mineralised zones at its APTA prospect in Colombia. Hole MAP-106A returned 229.7m at 0.88g/t Au, including higher-grade intervals of 7.65m at 7.07g/t Au, confirming potential for deeper and shallow gold targets.
Selected as one of three contractors for Transport for London's £700m Infrastructure Improvement Framework. The two-year agreement includes an optional two-year extension for major transportation projects across the capital.
Jubilee Metals Group said run-of-mine deliveries from its Molefe Mine to the Sable refinery have recommenced. The company targets a step-up to 10,000 tonnes per month by October 2026, representing a more than 100% increase in deliveries to the refinery.
Andrada Mining confirmed high-grade lithium mineralisation in the third batch of drill results from the Lithium Ridge Project. Results included 9.05m at 2.28% Li2O. The company has now completed its extended 16,525-metre Stage 1 drilling campaign.
First Development Resources secured a AU$100k government grant to support its Phase I drilling programme at the Lander West Gold Target. The fully funded programme is scheduled to commence in July 2026.
Wildcat appointed Niclas Biornstad as Technical Advisor for gold projects in Sudan. He is intended to join the board as a Non-Executive Director once the company is admitted to the Aquis Exchange and completes its first project acquisition.
Crimson Tide secured two new mpro5 trials with multi-site Costa Coffee operator Sim Trava and food manufacturer DW Baking. The Sim Trava agreement covers approximately 80 UK stores for one year.
London BTC Company staked 111 mineral claims at the Huntington-Whitman Gold-Silver Project in Nevada, marking its first gold hedge asset. The company will issue £20,000 in new ordinary shares to satisfy contractor fees for the staking and assessment.
Imaging Biometrics Limited reported Phase 1 trial results for oral gallium maltolate in recurrent glioblastoma. The trial established a recommended Phase 2 dose of 2,000 mg/day. Preliminary median overall survival reached 16 months, comparing favourably to historical data.
Aterian signed a long-term supply agreement with a Rwandan 3Ts producer. The company expects the deal to increase targeted trading revenues by 50% before the end of 2026.
The Gym Group plc announced it will publish a pre-close trading update for the six months ending 30 June 2026. The update is scheduled for release on 8 July 2026.
Michael Tobin purchased 5,810 shares at 478p. Following the transaction, he holds 900,000 shares in Audioboom Group plc, representing approximately 5.0% of the company's issued share capital.
LBG Media cut its full-year guidance for the second time in two months as structural declines in Indirect revenue offset 95% growth in its Direct business. The group now expects FY26 Adjusted EBITDA of 15m-20m after first-half profit before tax fell 79% to 1.8m.
Pets at Home Group Plc has posted its Annual Report and Accounts for the year ended 26 March 2026 and issued the Notice for its 2026 Annual General Meeting. The AGM is scheduled for 9 July 2026 in Handforth.
Proposed AIM Delisting & Notice of General Meeting
Silver Bullet Data Services Group plc proposes delisting from AIM and re-registering as a private company. Management cites approximately £0.5m of annual listing costs, which it considers disproportionately high relative to the benefits, and says the current share price does not reflect the Company's fundamental value. A shareholder vote is scheduled for 25 June 2026.
Clodagh Moriarty, an independent Non-Executive Director, is stepping down from the Board to focus on her role as Chief Executive of Dunelm Group plc. Taylor Wimpey has commenced a search for her replacement and will announce her leaving date in due course.
GSK has agreed to acquire Nuvalent for an aggregate equity value of $10.6 billion. The deal adds three products in lung cancer, including two late-stage, potential best-in-class ROS1 and ALK inhibitors for non-small cell lung cancer and a third asset, NVL-330, a potential best-in-class HER2 inhibitor, with subject-to-approval launches expected in 2026.